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Tuesday, November 15, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health threats/emergencies and we continue to address
ongoing/emerging disaster issues, the Center for Disaster Medicine (CDM) has been and will continue to be a source of reliable information, education
and models for mitigation, preparedness, response, and recovery. As such we have expanded this informational document to address the broader areas
addressed by the center while retaining critical COVID19 information. As the pace of new information and changes occur, we will evaluate the current
once per week to determine if this information should be provided on a more frequent basis

                                                                                                                       
David Markenson, M.D., M.B.A.
Director, Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

635,527,057

6,622,663

12,856,500,298

United States

98,045,358

1,074,688

626,206,433

New Jersey

918,876

11,537

18,283,404

New York

6,312,920

73,441

41,469,439

Connecticut

2,820,621

34,988

8,575,412

Information as of 11/14/22 at 0000 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Monkey Pox Statistics
State

Number of Cases

Connecticut

143

New Jersey

754

New York

4140

Total US Case Count

28947

CDC https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html

Center for Disaster Medicine Updates
Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continuing to partner with local organizations such as Westchester Department of Emergency Services and Westchester Medical
Center to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify strengths and areas for improvement in
other regions.
Updating and developing new programs to provide enhanced education on public health emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline responders in the hospital and in the
field.
Serving as a source of information for COVID-19 related concerns or questions regarding public health, emergency medical service
(EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using first-person
experiences to highlight current trends.

                                      

The White House
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic and monkeypox
and provide economic relief, tackle climate change, and advance racial equity and civil rights, as
well as immediate actions to reform our immigration system and restore America’s standing in the

world. This website will provide all information in one central location.
https://www.whitehouse.gov

COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website was
launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/

Health and Human Services (HHS)
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

Centers for Disease Control and Prevention (CDC)      
On November 11, 2022, the CDC released a MMWR regarding Interim
Recommendations from the Advisory Committee on Immunization Practices for the
Use of Bivalent Booster Doses of COVID-19 Vaccines — Bivalent COVID-19 vaccine
booster doses might improve protection against SARS-CoV-2 Omicron sublineages
and, along with completion of a primary series in persons who remain unvaccinated,
are important to protect against COVID-19, particularly among those persons who are
at increased risk for severe illness and death.
https://www.cdc.gov/mmwr/volumes/71/wr/mm7145a2.htm?s_cid=mm7145a2_x

On November 10, 2022, the CDC released the CDC Strategy for Global Response to
COVID-19 (2020-2023). This strategy provides an overarching framework for the U.S.
Centers for Disease Control and Prevention’s global response to the coronavirus
(COVID-19) pandemic. The CDC strategy aligns with the U.S. Government (USG)
strategy and the
U.S. National Security Strategic goals to protect the American people and ensure the
U.S. health security by mitigating the spread of infectious disease threats abroad,
ending the pandemic, and building resilience and readiness for future pandemics.
https://www.cdc.gov/coronavirus/2019-ncov/global-covid19/pdfs/CDCGlobalCOVIDStrategy_2020-2023.pdf?v=3
CDC provides updated information about the variants in the United States- The
emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are
significant to public health (e.g., causes more severe disease, spreads more easily
between humans, requires different treatments, changes the effectiveness of current
vaccines). It’s important to understand that genetic mutations are expected, and
some variants can spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths,
and trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

United States Food and Drug Administration (FDA)
As of November 8, 2022, 435 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 298 molecular
tests and sample collection devices, 85 antibody and other immune response tests,
51 antigen tests, and 1 diagnostic breath test. There are 77 molecular authorizations
and 1 antibody authorization that can be used with home-collected samples. There is
1 EUA for a molecular prescription at-home test, 2 EUAs for antigen prescription athome tests, 19 EUAs for antigen over-the-counter (OTC) at-home tests, and 4 for

molecular OTC at-home tests. The FDA has authorized 35 antigen tests and 8
molecular tests for serial screening programs. The FDA has also authorized 1153
revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-november-82022
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency
Use Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children
6 months to five years. On August 26, 2022, the FDA authorized the emergency use
of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus
Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in individuals 12 through 17 years of age. This authorization follows
a rigorous analysis and evaluation of the safety and effectiveness data conducted by
the FDA. On August 23, 2021, the FDA granted full approval to Pfizer for adults. On
January 31, 2022, the FDA granted full approval to Moderna for adults. Now with two
vaccines with full FDA approval and three vaccines with EUA for adults and children,
the goal is to vaccinate a larger number of persons in the coming months throughout
the United States. As additional vaccines are granted EUA, information for those
vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United StatesCDC provides overall US COVID-19 Vaccine, deliveries and administration, maps,
charts, and data updated daily by 8 PM. This section represents all vaccine partners
including jurisdictional partner clinics, retail pharmacies, long-term care facilities,
Federal Emergency Management Agency and Health Resources and Services
Administration partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard updates New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the
first and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
The NYS DOH provides updated monkeypox information regarding signs and
symptoms, cases, vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to
provide updated relevant information including side effects and safety data, clinical
trials demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of January 31, 2022, the fully
FDA approved Moderna vaccine will now be known as SPIKEVAX for ages six
months and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/differentvaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages six months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with
information to schedule vaccination appointments.

https://vaccinefinder.nyc.gov/

Educational Institution Information
Higher Education
International student enrollment bounced back last year after a steep
pandemic-fueled decline, according to a new “Open Doors” report from
the Institute of International Education. The total number of international
students in the U.S. increased by four percent in the 2021–22 academic
year and an additional nine percent this fall, following a 15 percent drop
in 2020–21. Allan Goodman, IIE’s CEO, said the rebound is consistent
with historical precedent. “We have more than 100 years of data on
international student mobility to the United States. This data includes 12
pandemics and shows that educational exchanges occur even during
them and grow rapidly afterwards,” he said.
https://www.insidehighered.com/news/2022/11/14/internationalstudents-are-coming-back-us-campuses
K-12
The number of youth under age 15 who contacted the National Runaway
Safeline soared by 53 percent during the pandemic, from 3,500 in 2019 to
5,366 in 2021, according to a report released last week. Children ages 12-14
are now the National Runaway Safeline’s fastest growing population. Within
the 53 percent increase, youth under 12 years of age contacting the safety line
jumped an “alarming” 153 percent, from 284 in 2019 to 718 in 2021. The
safeline called the overall jump in young people under age 15 reaching out for
help a “dramatic increase.” The percentage of children who cited family
dynamics as their reason for calling rose from 57 percent to 85 percent, and
those citing emotional abuse jumped 20 percent to 32 percent, in the two-year
span. The percentage of children reporting physical abuse nearly doubled
from 12 percent to 24 percent from 2019 to 2021, while those reaching out due
to mental health reasons increased 40 percent between the pandemic years of
2020 and 2021. https://www.k12dive.com/news/kids-under-12-runawaysafeline-ballooned-153-percent/636380/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?
recrs=&cond=Covid19&term=&cntry=&state=&city=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recoveredcovid-19-patients.html

State Updates
New York
·         Local medical experts say that several illnesses are spreading in our city and want to help New Yorkers stay safe.
The Centers for Disease Control and Prevention say there have been at least 2.8 million flu diagnoses this season.
Doctors at Kings County Hospital tell News 12 that they’re seeing many cases of not only the flu, but RSV and
COVID-19 as well. All three of these illnesses have similar symptoms on the surface, but Dr. Youssef says that there
are severe RSV symptoms that parents should be on the lookout for. "In pediatric patients, especially young babies, it
does tend to primarily affect the lungs, and it can prevent the baby from breathing too well,” said Youssef. “So, what
you want to look out for in those areas is poor feeding… some contractions in the lower spaces when breathing and
any sign that you just feel they may need a little help taking some breaths." RSV’s levels have
specifically spiked among younger New Yorkers. While there is no vaccine for RSV available to the public yet,
preventative measures such as washing your hands and wearing a mask can help keep RSV at
bay. https://bronx.news12.com/nyc-doctors-issue-warning-on-spread-of-rsv-flu-covid-19

New York State Department of Health (DOH)
On November 14, 2022, Governor Hochul updated New Yorkers on the state's progress combating COVID-19.   “This
November, I urge New Yorkers to remain vigilant and to use all available tools to keep themselves, their loved ones and
their communities safe and healthy," Governor Hochul said. "Stay up to date on vaccine doses, and test before gatherings
or travel. If you test positive, talk to your doctor about potential treatment options."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progress-combating-covid-19-382

For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information regarding testing, cases,
percentages, and fatalities across New York State. It also breaks down cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey

Local vaccine trial sites are recruiting young children to test COVID-19 bivalent doses more than two months after the vaccines were authorized
for use in adults, teens, and older children. Scientists will study the safety and efficacy of Pfizer-BioNTech’s bivalent shot in children as young as
six months old. “The assessment is really to look at how it compares to the monovalent [vaccines] and to see if it makes a difference,” said Simon
Li, associate professor of critical care at Rutgers Robert Wood Johnson Medical School and intensive care director for pediatrics at Bristol-Myers
Squibb Children’s Hospital. Bivalent vaccines developed by Pfizer-BioNTech and Moderna protect against not just the original strain of SARSCoV-2, but also an omicron variant. Scientists hope the updated formulas will better protect people against mutated coronaviruses.
https://whyy.org/articles/new-jersey-covid-bivalent-vaccines-children-under-five/

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of November 10, 2022, there are 3,758 cases of
monkeypox in New York City. For the latest information including cases, symptoms, testing, and vaccine information regarding monkeypox in New
York City, please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how variants of the virus that causes COVID-19 are
spreading in NYC. Variants are versions of the virus with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

Westchester County Department of Health
For the latest breakdown of COVID-19 positive cases in Westchester County as of November 14, 2022,
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.
https://health.westchestergov.com/2019-novel-coronavirus
As of November 14, 2022, Westchester County has 92 cases of monkeypox. Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court
Street, White Plains. Appointments are required. People at higher risk for monkeypox infection may consider vaccination with the two-dose JYNNEOS

vaccine. In accordance with CDC guidance, this includes those who:
Had contact with someone who had a rash that looks like monkeypox or with someone who was diagnosed with confirmed or probable
monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity; this includes men who have sex with men who
meet partners through an online website, digital application (“app”), or social event such as at a bar or party  
Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox activity has been ongoing
Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 am - 5 pm, appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/

Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of November 10, 2022.
https://www.putnamcountyny.com/covid19/
As of November 14, 2022, there are five cases of monkeypox in Putnam County.
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of November 11, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of November 14, 2022, there are 10 cases of monkeypox in Dutchess County. For the latest information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of November 10, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of November 14, 2022, there are 23 cases of monkeypox in Orange County. For more information regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of November 7, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of November 14, 2022, there is 17 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department website
https://rocklandgov.com/departments/health/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

   
                             Center for Disaster Medicine Media
Faculty News:
New Omicron Booster Side Effects Expected to Be Similar to Previous COVID-19 Shots
Healthline
9/21/2022
https://www.healthline.com/health-news/new-omicron-booster-side-effects-expected-to-be-similar-to-previous-covid-19-shots
Marisa A. Montecalvo, M.D., director of Health Services and professor of medicine

Every effort is made to provide accurate and complete information in this newsletter. However, New York Medical College cannot guarantee that
there will be no errors. NYMC makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents of the
newsletters or the articles linked herein and further expressly disclaims liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the advice of your physician or other qualified
health provider with any questions you may have regarding a medical condition.

New York Medical College
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